I’m hoping that IDT gets to produce Novavax vaccine which will realise short term revenue and manufacturing mRNA vaccines is longer term, more than 18 months away.
I wonder if they get a contract to produce say 50 million Novavax per year for 2 or 3 years could they borrow against that to make up their contribution of setting up the facility. If they can do that maybe don’t need a capital raise.
Ann: Supplementary Disclosure - Sterile Readiness Agreement, page-55
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.43M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.5¢ | $3.431K | 29.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 282984 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 380908 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IDT (ASX) Chart |